The bone remodeling environment is a factor in breast cancer bone metastasis

Bone

Volumn 48, Issue 1, 2011, Pages 66-70

  Ooi, Li Laine ^a   Zheng, Yu ^a   Stalgis Bilinski, Kellie ^a   Dunstan, Colin R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Breast cancer; Calcium; Metastasis; Osteoblasts; Osteoclasts; Vitamin D

Indexed keywords

CALCIFEDIOL; CALCITRIOL; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE RELATED PROTEIN;

BONE DESTRUCTION; BONE METASTASIS; BONE REMODELING; BONE TURNOVER; BREAST CANCER; CALCIUM DEFICIENCY; CELL HOMING; CELL INTERACTION; HUMAN; IMMUNOMODULATION; MICROMETASTASIS; NONHUMAN; OSTEOCLAST; REVIEW; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME; VITAMIN D DEFICIENCY;

ANIMALS; BONE AND BONES; BONE NEOPLASMS; BONE REMODELING; BREAST NEOPLASMS; CALCIUM; FEMALE; HUMANS; MICE; MICE, NUDE; TUMOR MICROENVIRONMENT; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 78650305549     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.05.007     Document Type: Review

References (36)

1. Quinn J.M., Matsumura Y., Tarin D., McGee J.O., Athanasou N.A. Cellular and hormonal mechanisms associated with malignant bone resorption. Lab Invest 1994, 71:465-471.
2. Clines G.A., Guise T.A. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. Endocr Relat Cancer 2005, 12:549-583.
3. Hofbauer L.C., Khosla S., Dunstan C.R., Lacey D.L., Boyle W.J., Riggs B.L. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000, 15:2-12.
4. Yin J.J., Selander K., Chirgwin J.M., et al. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 1999, 103:197-206.
5. Bendre M.S., Montague D.C., Peery T., Akel N.S., Gaddy D., Suva L.J. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone 2003, 33:28-37.
6. Tsubaki M., Kato C., Manno M., Ogaki M., Satou T., Itoh T., et al. Macrophage inflammatory protein-1alpha (MIP-1alpha) enhances a receptor activator of nuclear factor kappaB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K/Akt pathways. Mol Cell Biochem 2007, 304:53-60.
7. de la Mata J., Uy H.L., Guise T.A., Story B., Boyce B.F., Mundy G.R., et al. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J Clin Invest 1995, 95:2846-2852.
8. Mundy G.R. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002, 2:584-593.
9. Zheng Y., Zhou H., Brennan K., Blair J.M., Modzelewski J.R.K., Seibel M.J., et al. Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis. Bone 2007, 40:471-478.
10. Morony S., Capparelli C., Sarosi I., Lacey D.L., Dunstan C.R., Kostenuik P.J. Osteoprotegerin (OPG) inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis. Cancer Res 2001, 61:4432-4436.
11. Saito H., Tsunenari T., Onuma E., Sato K., Ogata E., Yamada-Okabe H. Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231. Anticancer Res 2005, 25:3817-3823.
12. van der Pluijm G., Que I., Sijmons B., Buijs J.T., Löwik C.W., Wetterwald A., et al. Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivo. Cancer Res 2005, 65:7682-7690.
13. Wendt M.K., Cooper A.N., Dwinell M.B. Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells. Oncogene 2008, 27:1461-1471.
14. Wang J., Loberg R., Taichman R.S. The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis. Cancer Metastasis Rev 2006, 25:573-587.
15. Ooi L.L., Dunstan C.R. CXCL12/CXCR4 axis in tissue targeting and bone destruction in cancer and multiple myeloma. J Bone Miner Res 2009, 24:1147-1149.
16. Strell C., Lang K., Niggemann B., Zaenker K.S., Entschladen F. Surface molecules regulating rolling and adhesion to endothelium of neutrophil granulocytes and MDA-MB-468 breast carcinoma cells and their interaction. Cell Mol Life Sci 2007, 64:3306-3316.
17. Kuo Y.C., Su C.H., Liu C.Y., Chen T.H., Chen C.P., Wang H.S. Transforming growth factor-beta induces CD44 cleavage that promotes migration of MDA-MB-435s cells through the up-regulation of membrane type 1-matrix metalloproteinase. Int J Cancer 2009, 124:2568-2576.
18. Diamond P., Labrinidis A., Martin S.K., Farrugia A.N., Gronthos S., To L.B., et al. Targeted disruption of the CXCL12/CXCR4 axis inhibits osteolysis in a murine model of myeloma-associated bone loss. Bone Miner Res 2009, 24:1150-1161.
19. Luzzi K.J., MacDonald I.C., Schmidt E.E., et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998, 153:865-873.
20. Li C.Y., Shan S., Cao Y., Dewhirst M.W. Role of incipient angiogenesis in cancer metastasis. Cancer Metastasis Rev 2000, 19:7-11.
21. Guise T.A., Mundy G.R. Cancer and bone. Endocr Rev 1998, 19:18-54.
22. Mundy G.R. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002, 2:584-593.
23. Menu E., De Leenheer E., De Raeve H., Coulton L., Imanishi T., Miyashita K., et al. Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model. Clin Exp Metastasis 2006, 23:291-300.
24. Yoneda T., Sasaki A., Dunstan C., Williams P.J., Bauss F., De Clerck Y.A., et al. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. J Clin Invest 1997, 99:2509-2517.
25. Hirbe A.C., Uluçkan O., Morgan E.A., Eagleton M.C., Prior J.L., Piwnica-Worms D., et al. Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner. Blood 2007, 109:3424-3431.
26. Das Roy L., Pathangey L.B., Tinder T.L., Schettini J.L., Gruber H.E., Mukherjee P. Breast-cancer-associated metastasis is significantly increased in a model of autoimmune arthritis. Breast Cancer Res 2009, 11(4):R56.
27. Libouban H., Moreau M.F., Basle M.F., Bataille R., Chappard D. Increased bone remodeling due to ovariectomy dramatically increases tumoral growth in the 5T2 multiple myeloma mouse model. Bone 2003, 33:283-292.
28. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
29. Holick M.F., Chen T.C. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008, 87:1080S-1086S.
30. Goodwin P.J., Ennis M., Pritchard K.I., Koo J., Hood N. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 2009, 27:3757-3763.
31. Zheng Y., Zhou H., Modzelewski J.R., et al. Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone. Cancer Res 2007, 67:9542-9548.
32. Ooi L.L., Zhou H., Kalak R., et al. Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis. Cancer Res 2010, 70:1835-1844.
33. Zheng Y., Zhou H., Fong-Yee C., Modzelewski J.R., Seibel M.J., Dunstan C.R. Bone resorption increases tumour growth in a mouse model of osteosclerotic breast cancer metastasis. Clin Exp Metastasis 2008, 25:559-567.
34. Mastro A.M., Gay C.V., Welch D.R., Donahue H.J., Jewell J., Mercer R., et al. Breast cancer cells induce osteoblast apoptosis: a possible contributor to bone degradation. J Cell Biochem 2004, 91:265-276.
35. Abbas S., Linseisen J., Slanger T., et al. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer-results of a large case-control study. Carcinogenesis 2008, 29:93-99.
36. Neuhouser M.L., Sorensen B., Hollis B.W., et al. Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr 2008, 88:133-139.